Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Pegasys
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pegasys 135micrograms/0.5ml inj pre-filled syringes
0802040A0BDABAG
|
Pegasys | Peginterferon alpha | Malignant Disease and Immunosuppression | 3 |
|
Pegasys 90micrograms/0.5ml inj pre-filled syringes
0802040A0BDAEAP
|
Pegasys | Peginterferon alpha | Malignant Disease and Immunosuppression | 2 |
|
Pegasys 135micrograms/0.5ml inj pre-filled pens
0802040A0BDACAM
|
Pegasys | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Pegasys 180micrograms/0.5ml inj pre-filled pens
0802040A0BDADAN
|
Pegasys | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Pegasys 180micrograms/0.5ml inj pre-filled syringes
0802040A0BDAAAF
|
Pegasys | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.